Chaoju Eye Care Holdings Limited will convene its 2026 annual general meeting on 12 May 2026 in Beijing. The Board is submitting five key resolutions to shareholders:

1. General mandates • Issuance: Directors seek authority to allot or transfer up to 20% of issued share capital, equal to 141.04 million new or treasury shares, based on the 705.18 million shares outstanding on 15 April 2026. • Repurchase: A parallel mandate would allow buy-backs of up to 10% of issued shares, or 70.52 million shares. Repurchased stock may be cancelled or held as treasury shares, subject to Listing Rules. An additional mandate would extend the issuance limit by the amount of shares actually repurchased.

2. Board composition Four directors—Chairman & CEO Zhang Bozhou, Executive Director Zhang Guangdi, and Independent Non-executive Directors He Mingguang and Guo Hongyan—stand for re-election.

3. Dividend proposal The Board recommends a final dividend of HK$0.2423 per share for FY 2025. Shareholders on record as of 20 May 2026 will be eligible, with the register closed 18–20 May 2026.

4. Auditor Ernst & Young is nominated for re-appointment as external auditor for another term.

Key timetable • Last day to lodge transfers for AGM attendance: 6 May 2026 • Register closure for AGM: 7–12 May 2026 • AGM date: 12 May 2026 • Last day to lodge transfers for dividend: 15 May 2026 • Register closure for dividend: 18–20 May 2026

If all resolutions pass, the refreshed mandates will give the company flexibility to raise capital, manage its share base, and return cash to shareholders while maintaining compliance with Hong Kong listing and Cayman Companies Act requirements.